Barely Significant
← all excerpts

Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use.

Card Fail Rev · 2020 · PMC7374352 · PMID 32714567

Europe PMCDOI
1
hedged sentence
0.5300
closest p · 10.6× alpha
0.5300
boldest claim

The sentences

a numerical trendp=0.53not close (p > 0.1)
collected data from 5,480 patients in 45 randomised clinical trials and also carried out a meta-analysis of the adverse events.[ 67 ] No signals were seen for MI (data from 25 studies, RR 0.789, 95% CI [0.522–1.185], p=0.3), ventricular arrhythmias (data from nine studies, RR 0.885, 95% CI [0.611–1.281], p=0.5) or supraventricular arrhythmias (data from 19 studies, RR 1.005, 95% CI [0.782–1.291], p=0.9), but a numerical trend was seen for hypotension (data from 22 studies, RR 1.389, 95% CI [0.996–1.936], p=0.53).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.